VTN and COVID-19: The causative agent of COVID‐19 has an abundant display of glycoproteins on its outer surface, and these could form potential ligands for several pattern recognition molecules (e.g. collectins) that are produced in the lungs along with other complement proteins, notably by type II alveolar cells and macrophages.